Adam Crystal - 29 Jul 2021 Form 4 Insider Report for C4 Therapeutics, Inc. (CCCC)

Role
Chief Medical Officer
Signature
/s/ Shoaib Ghias, Attorney-in-Fact
Issuer symbol
CCCC
Transactions as of
29 Jul 2021
Net transactions value
-$600,300
Form type
4
Filing time
02 Aug 2021, 18:44:54 UTC
Previous filing
06 Jul 2021
Next filing
05 Oct 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CCCC Common Stock Options Exercise $74,700 +15,000 $4.98 15,000 29 Jul 2021 Direct
transaction CCCC Common Stock Sale $675,000 -15,000 -100% $45.00* 0 29 Jul 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CCCC Stock Option (Right to Buy) Options Exercise $0 -15,000 -7.6% $0.000000 183,108 29 Jul 2021 Common Stock 15,000 $4.98 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on January 21, 2021.
F2 This option shall vest and become exercisable in 20 equal quarterly installments, with the first installment vesting on September 5, 2020.